Stifel analyst Benjamin J. Burnett upgraded eFFECTOR Therapeutics, Inc. (NASDAQ: EFTR) from ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE